Explore

Trendline Trendline
Versant Sells SportsEngine to Playmetrics Amid Strategic Refocus

Versant Sells SportsEngine to Playmetrics Amid Strategic Refocus

Versant Sells SportsEngine to Playmetrics Amid Strategic Refocus
Trendline Trendline
Versant Sells SportsEngine to PlayMetrics, Shifts Focus in Sports Strategy

Versant Sells SportsEngine to PlayMetrics, Shifts Focus in Sports Strategy

Versant Sells SportsEngine to PlayMetrics, Shifts Focus in Sports Strategy
Trendline Trendline
iAltA Holdings Acquires Precept to Enhance Wealthtech Integrations

iAltA Holdings Acquires Precept to Enhance Wealthtech Integrations

iAltA Holdings Acquires Precept to Enhance Wealthtech Integrations
Trendline Trendline
Render Networks Expands Beyond FTTH with New Funding and Acquisition

Render Networks Expands Beyond FTTH with New Funding and Acquisition

Render Networks Expands Beyond FTTH with New Funding and Acquisition
Trendline Trendline
iAltA Holdings Acquires Precept to Enhance Wealth Technology Integration

iAltA Holdings Acquires Precept to Enhance Wealth Technology Integration

iAltA Holdings Acquires Precept to Enhance Wealth Technology Integration
Trendline Trendline
Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options
Trendline Trendline
Kone Acquires TK Elevator in €29.4 Billion Deal, Expanding US Market Presence

Kone Acquires TK Elevator in €29.4 Billion Deal, Expanding US Market Presence

Kone Acquires TK Elevator in €29.4 Billion Deal, Expanding US Market Presence
Trendline Trendline
Chiesi Acquires KalVista for $1.9 Billion, Expanding Rare Disease Portfolio

Chiesi Acquires KalVista for $1.9 Billion, Expanding Rare Disease Portfolio

Chiesi Acquires KalVista for $1.9 Billion, Expanding Rare Disease Portfolio
Trendline Trendline
Estée Lauder Considers Acquisition of Puig with Tender Offer for Shares

Estée Lauder Considers Acquisition of Puig with Tender Offer for Shares

Estée Lauder Considers Acquisition of Puig with Tender Offer for Shares
Trendline Trendline
Organon Cancels Q1 2026 Earnings Call Amid Acquisition by Sun Pharmaceutical

Organon Cancels Q1 2026 Earnings Call Amid Acquisition by Sun Pharmaceutical

Organon Cancels Q1 2026 Earnings Call Amid Acquisition by Sun Pharmaceutical
Trendline Trendline
Equiniti Launches DealTrax Platform to Streamline Corporate Actions and M

Equiniti Launches DealTrax Platform to Streamline Corporate Actions and M

Equiniti Launches DealTrax Platform to Streamline Corporate Actions and M
Trendline Trendline
Amadeus to Acquire French Biometrics Firm Idemia Public Security

Amadeus to Acquire French Biometrics Firm Idemia Public Security

Amadeus to Acquire French Biometrics Firm Idemia Public Security